LLY

798.21

+0.15%↑

JNJ

152.19

-0.36%↓

ABBV

186.67

+0.02%↑

NVO

68.84

+1.16%↑

UNH

304.8

-0.09%↓

LLY

798.21

+0.15%↑

JNJ

152.19

-0.36%↓

ABBV

186.67

+0.02%↑

NVO

68.84

+1.16%↑

UNH

304.8

-0.09%↓

LLY

798.21

+0.15%↑

JNJ

152.19

-0.36%↓

ABBV

186.67

+0.02%↑

NVO

68.84

+1.16%↑

UNH

304.8

-0.09%↓

LLY

798.21

+0.15%↑

JNJ

152.19

-0.36%↓

ABBV

186.67

+0.02%↑

NVO

68.84

+1.16%↑

UNH

304.8

-0.09%↓

LLY

798.21

+0.15%↑

JNJ

152.19

-0.36%↓

ABBV

186.67

+0.02%↑

NVO

68.84

+1.16%↑

UNH

304.8

-0.09%↓

Search

DexCom Inc

Abrir

SetorSaúde

85.98 0.64

Visão Geral

Variação de preço das ações

24h

Atual

Mín

84.36

Máximo

86.35

Indicadores-chave

By Trading Economics

Rendimento

-46M

105M

Vendas

-78M

1B

P/E

Médio do Setor

60.03

50.291

EPS

0.32

Margem de lucro

10.174

Funcionários

10,200

EBITDA

-109M

134M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+16.96% upside

Dividendos

By Dow Jones

Próximos Ganhos

24 de jul. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-3.3B

31B

Abertura anterior

85.34

Fecho anterior

85.98

Sentimento de Notícias

By Acuity

50%

50%

154 / 380 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

DexCom Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

25 de out. de 2024, 09:10 UTC

Ganhos

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

26 de jul. de 2024, 20:16 UTC

Ganhos

These Stocks Moved the Most Today: DexCom, 3M, Nvidia, Bristol Myers, Coursera, Biogen, Charter, Deckers, and More -- Barrons.com

26 de jul. de 2024, 09:13 UTC

Principais Notícias
Ações em Alta

Stocks to Watch: DexCom, Coinbase, 3M, Hermès -- WSJ

26 de jul. de 2024, 08:56 UTC

Principais Notícias

These Stocks Are Moving the Most Today: DexCom, Deckers, Coursera, Ford, Alphabet, Bristol Myers, 3M, and More -- Barrons.com

27 de jun. de 2024, 16:01 UTC

Ganhos

ResMed Stock Is Down Because of GLP-1 Concerns. It Shouldn't Be. -- Barrons.com

Comparação entre Pares

Variação de preço

DexCom Inc Previsão

Preço-alvo

By TipRanks

16.96% parte superior

Previsão para 12 meses

Média 99.04 USD  16.96%

Máximo 110 USD

Mínimo 85 USD

Com base em 20 analistas de Wall Street que oferecem metas de preço de 12 meses para DexCom Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

20 ratings

19

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

71.66 / N/ASuporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

Bullish Evidence

Longo Prazo

Neutral Evidence

Sentimento

By Acuity

154 / 380 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre DexCom Inc

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.